Similar articles

• Neuro-endocrine disorders seen as triggers of the triad: obesity--insulin resistance--abnormal glucose tolerance.

  Jeanrenaud B, Halimi S, van de Werve G. Jeanrenaud B, et al. Diabetes Metab Rev. 1985;1(3):261-91. doi: 10.1002/dmr.5610010303. Diabetes Metab Rev. 1985. PMID: 3915255 Review. No abstract available.
• Endocrine function in human obesity.

  Glass AR, Burman KD, Dahms WT, Boehm TM. Glass AR, et al. Metabolism. 1981 Jan;30(1):89-104. doi: 10.1016/0026-0495(81)90224-9. Metabolism. 1981. PMID: 6780754 Review. No abstract available.
• Opioid peptides and depression: the neuroendocrine approach.

  Zis AP, Garland JE. Zis AP, et al. Baillieres Clin Endocrinol Metab. 1991 Mar;5(1):97-117. doi: 10.1016/s0950-351x(05)80099-0. Baillieres Clin Endocrinol Metab. 1991. PMID: 2039430 Review. No abstract available.
• [Dysfunctions of the existing axis between the central nervous system and the endocrine pancreas in experimental and genetic obesity in the rodent].

  Jeanrenaud B, Ionescu E, Rohner-Jeanrenaud F. Jeanrenaud B, et al. Journ Annu Diabetol Hotel Dieu. 1984:39-44. Journ Annu Diabetol Hotel Dieu. 1984. PMID: 6100382 Review. French. No abstract available.
• The origins and role of efferent vagal nuclei in hyperinsulinemia in hypothalamic and genetically obese rodents.

  Rohner-Jeanrenaud F, Ionescu E, Jeanrenaud B. Rohner-Jeanrenaud F, et al. J Auton Nerv Syst. 1983 Oct;9(1):173-84. doi: 10.1016/0165-1838(83)90139-x. J Auton Nerv Syst. 1983. PMID: 6363496